Features of the clinical course of chronic obstructive pulmonary disease and quality of life in patients with coexisting metabolic syndrome

Cover Page


Cite item

Full Text

Abstract

Aim. To study the clinical course of chronic obstructive pulmonary disease in patients with metabolic syndrome and analyze the degree of influence of the metabolic syndrome components on chronic obstructive pulmonary disease and patients’ quality of life.

Methods. 100 patients with chronic obstructive pulmonary disease were examined: 30 patients without metabolic syndrome (the first group) and 70 patients with metabolic syndrome (the second group). Anthropometric measurements (weight, height, body mass index, waist circumference), laboratory tests (levels of triglycerides, cholesterol, low- and high-density lipoproteins, fasting blood glucose, the oral glucose tolerance test), physical examination, quality of life assessment were performed.

Results.Patients of the second group had statistically significant differences in the studied parameters in comparison with the first group. The number of exacerbations, calls to ambulance service, hospital admissions were 1.4; 1.3 and 1.5 times higher, respectively. Dyspnea intensity, cough and sputum score were 1.6; 1.7 and 1.6 times higher respectively as compared with the first group (p

Conclusion. Metabolic syndrome is associated with a more severe course of chronic obstructive pulmonary disease, which results in a higher frequency of exacerbations, hospital admissions, more severe clinical manifestations, greater influence of dyspnea on the physical activity limitation of patients, more severe airflow obstruction, low exercise tolerance with worse performance of everyday activities, emotional perception of the disease, worse psychosocial adaptation of patients.

About the authors

S A Kozhevnikova

Voronezh State Medical University named after N.N. Burdenko

Author for correspondence.
Email: kozhevnikova_s_a@mail.ru

A V Budnevskiy

Voronezh State Medical University named after N.N. Burdenko

Email: kozhevnikova_s_a@mail.ru

References

  1. Авдеев С.Н. Клинические симптомы и качество жизни пациентов с хронической обструктивной болезнью лёгких: субъективно оцениваемые показатели или факторы, определяющие прогноз? Пульмонология. 2016; (2): 231-237.
  2. Бачинский О.Н., Бабкина В.И., Племенова Е.Ю. Системное воспаление при хронической обструктивной болезни лёгких различного генеза. Фундаментал. исслед. 2009; (4): 47-48.
  3. Глобальная стратегия диагностики, лечения и профилактики хронической обструктивной болезни лёгких = Global Initiative for Chronic Obstructive Lung Disease (GOLD, пересмотр 2016). http://www.goldcopd.org (дата обращения: 16.05.16). .
  4. Рекомендации по ведению больных с метаболическим синдромом. Клинические рекомендации. М. 2013; 43 с.
  5. Рязанов А.С., Киреев С.А., Ерёменко Н.Н. Особенности клинического течения ХОБЛ при метаболическом синдроме: роль системного воспаления. Ожирение и метаболизм. 2010; (2): 49-51.
  6. Чучалин А.Г., Авдеев С.Н., Айсанов З.Р. и др. Российское респираторное общество: Федеральные клинические рекомендации по диагностике и лечению хронической обструктивной болезни лёгких. Пульмонология. 2014; (3): 15-54.
  7. Akpinar E.E., Akpinar S., Ertek S. et al. Systemic inflammation and metabolic syndrome in stable COPD patients. Tuberk. Toraks. 2012; 60 (3): 230-237. http://dx.doi.org/10.5578/tt.4018
  8. Park S.K., Larson J.L. Metabolic syndrome and associated factors in people with chronic obstructive pulmonary disease. West J. Nurs. Res. 2014; 36 (5): 620-642. http://dx.doi.org/10.1177/0193945913512423

Supplementary files

Supplementary Files
Action
1. JATS XML

© 2016 Kozhevnikova S.A., Budnevskiy A.V.

Creative Commons License

This work is licensed
under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.





This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies